Anixa Biosciences

ANIX60

Penny Stock

$3.15arrow_drop_up4.91%$0.15

Penny Stock

ANIX60

$3.15

arrow_drop_up4.91%$0.15

Penny Stock

Performance History

Key Stats
Open	$3.05
Prev. Close	$3.05
EPS	-0.39
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$103.61M
PE Ratio	-

	LOW	HIGH
Day Range	3.06	3.24
52 Week Range	2.15	5.13

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-0.39

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Anixa Biosciences (ANIX)

Anixa Biosciences Inc (ANIX) is a biotechnology company that focuses on the development of innovative diagnostics and therapeutics for cancer. The company is headquartered in San Jose, California, and was founded in 1982. ANIX stock has been listed on the NASDAQ stock exchange since 1996.

The stock price history of Anixa Biosciences Inc (ANIX) has shown both volatility and growth over the years. It has experienced significant fluctuations in response to various factors such as clinical trial results, regulatory approvals, and market sentiment. Investors interested in ANIX stock should closely monitor these factors as they can have a significant impact on the stock price.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Amit Kumar Ph.D.
Headquarters: San Jose
Employees: 4
Exchange: NASDAQ

Keep an eye on Anixa Biosciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Anixa Biosciences 's (ANIX) price per share?

The current price per share for Anixa Biosciences (ANIX) is $3.15. The stock has seen a price change of $0.15 recently, indicating a 4.92% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Anixa Biosciences (ANIX)?

For Anixa Biosciences (ANIX), the 52-week high is $5.13, which is 62.6% from the current price. The 52-week low is $2.15, the current price is 46.74% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Anixa Biosciences (ANIX) a growth stock?

Anixa Biosciences (ANIX) has shown an average price growth of -6.8% over the past three years. It has received a score of 42 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Anixa Biosciences as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Anixa Biosciences (ANIX) stock price performance year to date (YTD)?

As of the latest data, Anixa Biosciences (ANIX) has a year-to-date price change of -19.72%. Over the past month, the stock has experienced a price change of 4.82%. Over the last three months, the change has been -1.1%. Over the past six months, the figure is 11.09%. Looking at a longer horizon, the five-year price change stands at -15.64%.

help

Is Anixa Biosciences (ANIX) a profitable company?

Anixa Biosciences (ANIX) has a net income of -$9.93M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 23.33% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. The gross profit is $49K. Operating income is noted at -$11.01M. Furthermore, the EBITDA is $0.

help

What is the market capitalization of Anixa Biosciences (ANIX)?

Anixa Biosciences (ANIX) has a market capitalization of $103.62M. The average daily trading volume is 3.14, indicating the stock's liquidity and investor engagement.